help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ragavan, V. V.
Right arrow Articles by Frantz, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ragavan, V. V.
Right arrow Articles by Frantz, A. G.

Endocrinology, Vol 109, 1769-1771, Copyright © 1981 by Endocrine Society

ARTICLES

Opioid regulation of prolactin secretion: evidence for a specific role of beta-endorphin

VV Ragavan and AG Frantz

Previous studies have shown that exogenously administered opioids, including beta-endorphin, stimulate prolactin release. The fact that naloxone has been shown to lower baseline and stress-induced serum prolactin in rats suggests that endogenous opioids may participate in prolactin regulation, but does not specify which opioid is involved. In a previous study we showed that intravenously administered anti-beta- endorphin antiserum had no effect on either baseline or stress-induced prolactin release in rats. In the present study we have repeated our earlier experiments, but have given the antiserum into the cerebral ventricles rather than intravenously. Significant lowering of baseline serum prolactin, to 56.6% +/- 10.6% (SEM) that of controls (p less than 0.005), was noted. Also noted was blunting of the stress-induced prolactin rise, to 69.2% +/- 6.7% that of controls (p less than 0.002). These results indicate that beta-endorphin is specifically involved in both the tonic and stress-mediated release of prolactin. Because the magnitude of prolactin lowering with antiserum was at least as great as what we had earlier observed with naloxone, they suggest that beta- endorphin is the major and possibly the sole opioid involved in prolactin regulation. They also indicate that the previous lack of effect of anti-beta-endorphin antiserum on serum prolactin was due to its failure, after intravenous administration, to achieve effective concentration at critical controlling sites within the brain.


This article has been cited by other articles:


Home page
 Ann. N. Y. Acad. Sci.Home page
B RADNAI, B MRAVEC, I BODNAR, L KUBOVCAKOVA, F FULOP, M I K FEKETE, G M NAGY, and R KVETNANSKY
Pivotal Role of an Endogenous Tetrahydroisoquinoline, Salsolinol, in Stress- and Suckling-Induced Release of Prolactin
Ann. N.Y. Acad. Sci., June 1, 2004; 1018(1): 183 - 191.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
R Guieu, H Dufour, C Devaux, T Brue, J P Rosso, F Grisoli, M Grino, A Enjalbert, D Begoud, N Broder, et al.
The hormonal response to stress is not modified by the dramatic decrease in prolactin plasma concentration during surgery for microprolactinoma
J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 502 - 507.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society